Global Growth Companies With Significant Insider Ownership
As global markets navigate a landscape marked by record highs in major U.S. stock indexes and geopolitical developments influencing investor sentiment, the focus on growth companies with significant insider ownership becomes increasingly relevant. In such an environment, stocks that combine robust growth potential with high insider ownership are often seen as attractive due to the alignment of interests between company insiders and shareholders.
Top 10 Growth Companies With High Insider Ownership Globally
| Name | Insider Ownership | Earnings Growth |
| Shanghai Biren Technology (SEHK:6082) | 11% | 116.9% |
| Seojin SystemLtd (KOSDAQ:A178320) | 18% | 110.6% |
| Meitu (SEHK:1357) | 22.8% | 31.3% |
| Meiko Electronics (TSE:6787) | 19.2% | 30.1% |
| KebNi (OM:KEBNI B) | 11.8% | 90.9% |
| Gpixel Changchun Microelectronics (SEHK:3277) | 18.2% | 34.2% |
| Gold Circuit Electronics (TWSE:2368) | 30.1% | 43.8% |
| CD Projekt (WSE:CDR) | 35.2% | 39% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 14.1% | 41% |
| ASE Technology Holding (TWSE:3711) | 25.7% | 37.5% |
Let's explore several standout options from the results in the screener.
Shanghai Beite Technology group (SHSE:603009)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Shanghai Beite Technology Group Co., Ltd. operates in the technology sector and has a market cap of approximately CN¥15.24 billion.
Operations: Shanghai Beite Technology Group Co., Ltd. has not provided specific revenue segment details in the available data.
Insider Ownership: 38.9%
Revenue Growth Forecast: 19.2% p.a.
Shanghai Beite Technology Group exhibits strong growth potential with forecasted earnings growth of 27.9% annually, outpacing the broader Chinese market. Despite slower revenue growth at 19.2% per year, it still surpasses the market average. The company has a high projected return on equity of 29.1%, indicating efficient profit generation relative to shareholder equity. No significant insider trading activity is reported over the past three months, suggesting stability in insider sentiment toward future prospects.
- Click here to discover the nuances of Shanghai Beite Technology group with our detailed analytical future growth report.
- Our valuation report here indicates Shanghai Beite Technology group may be overvalued.
PharmaResources (Shanghai) (SZSE:301230)
Simply Wall St Growth Rating: ★★★★★☆
Overview: PharmaResources (Shanghai) Co., Ltd. operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing for pharmaceutical and biotechnology companies both in China and internationally, with a market cap of CN¥6.79 billion.
Operations: PharmaResources generates revenue through its comprehensive services in drug research, development, and commercial manufacturing for pharmaceutical and biotech firms globally.
Insider Ownership: 13.5%
Revenue Growth Forecast: 25.8% p.a.
PharmaResources (Shanghai) demonstrates robust growth prospects with earnings projected to grow 35.2% annually, surpassing the Chinese market's average. Revenue is also expected to increase at a strong rate of 25.8% per year, outpacing market growth. However, despite these positive forecasts, the company's return on equity is anticipated to remain low at 8.4%. Recent dividend affirmations highlight shareholder returns, though earnings quality is impacted by large one-off items and share price volatility persists.
- Dive into the specifics of PharmaResources (Shanghai) here with our thorough growth forecast report.
- Our valuation report unveils the possibility PharmaResources (Shanghai)'s shares may be trading at a premium.
Kaori Heat Treatment (TWSE:8996)
Simply Wall St Growth Rating: ★★★★★★
Overview: Kaori Heat Treatment Co., Ltd. specializes in the research, development, manufacture, and sale of heat exchangers and thermal energy products across Taiwan, Asia, the United States, Europe, and internationally with a market cap of NT$98.92 billion.
Operations: The company's revenue is primarily derived from two segments: Plate Heat Exchanger, contributing NT$1.82 billion, and Fuel, Electricity, and Thermal Energy, accounting for NT$7.17 billion.
Insider Ownership: 10.5%
Revenue Growth Forecast: 51.6% p.a.
Kaori Heat Treatment shows strong growth potential with earnings projected to rise 57.2% annually, significantly outpacing the Taiwanese market. Revenue is also expected to grow at a robust 51.6% per year, surpassing market averages. Recent first-quarter results revealed substantial sales and net income increases, indicating positive momentum. Despite high forecasted return on equity of 57.7%, the stock has experienced volatility recently, and there is no significant insider trading activity reported over the past three months.
- Click here and access our complete growth analysis report to understand the dynamics of Kaori Heat Treatment.
- Our comprehensive valuation report raises the possibility that Kaori Heat Treatment is priced higher than what may be justified by its financials.
Seize The Opportunity
- Dive into all 727 of the Fast Growing Global Companies With High Insider Ownership we have identified here.
- Want To Explore Some Alternatives? Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com